| MSD Merck Sharp & Dohme AG - M-M-RVAXPRO, Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | | 00703 | | 01 | | M-M-RVAXPRO | | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | | J07BD52 | | Masern, Kombinationen mit Mumps und Röteln, lebend abgeschwächt | | 13.02.2007 | | |
| | Composition | | Vaccinum attenuatum: virus morbilli vivus (Stamm Edmonston-Enders) min. 1000 U., virus parotitis vivus (Stamm Jeryl Lynn) min. 12500 U., virus rubella vivus (Stamm Wistar RA 27/3) min. 1000 U., gelatina hydrolysata, medium 199, minimal essential medium (MEM), natrii hydrogenoglutamas monohydricus, neomycinum, phenolsulfonphthaleinum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, natrii hydrogenocarbonas, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, sorbitolum 14.5 mg, saccharum, albuminum humanum, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium 2.45 mg et kalium 0.09 mg.
Solvens: aqua ad iniectabile. | | Packungsbestandteile | | Solvens | | | aqua ad iniectabile 0.5 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Virus Morbilli Vivus (Stamm: Ender's Edmonston) | 1000 U | | Virus Parotitis Vivus (Stamm: Jeryl lynn (Level B)) | 12500 U | | Virus Rubella Vivus (Stamm Wistar ra 27/3) | 1000 U |
|
| Lyophilisat et solvant | | | | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Virus Morbilli Vivus (Stamm Edmonston-Enders) | 1000 U | Vaccinum attenuatum | | Virus Parotitis Vivus (Stamm Jeryl Lynn) | 12500 U | | | Virus Rubella Vivus (Stamm Wistar ra 27/3) | 1000 U | |
| | BAG: Principe actif | Concentr. |
|---|
| Virus Morbilli Vivus (Stamm: Ender's Edmonston) | 1000 U | | Virus Parotitis Vivus (Stamm: Jeryl lynn (Level B)) | 12500 U | | Virus Rubella Vivus (Stamm Wistar ra 27/3) | 1000 U |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum | | | Albumine Humaine | | | Dipotassium Phosphate Anhydre | | | Disodium Phosphate Dihydrate | | | Gelatina Hydrolysata | | | Potassium Dihydrogenophosphate | | | Medium | 199 | | Minimal Essential Medium (Mem) | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydrogenocarbonate | | | Natrii Hydrogenoglutamas Monohydricus | | | Sodium Hydroxide | | | Neomycine | | | Phenolsulfonphthaleinum | | | Saccharum | | | Sorbitol | 14.5 mg |
| |
| Solvens | | | aqua ad iniectabile | | | | | | BAG: Principe actif | Concentr. |
|---|
| Virus Morbilli Vivus (Stamm: Ender's Edmonston) | 1000 U | | Virus Parotitis Vivus (Stamm: Jeryl lynn (Level B)) | 12500 U | | Virus Rubella Vivus (Stamm Wistar ra 27/3) | 1000 U |
|
| |
|
